Longer PSA Monitoring in Patients With Persistent PSA May Reduce Overtreatment
THURSDAY, March 27, 2025 -- Assessment of prostate-specific antigen (PSA) level for three months after radical prostatectomy (RP) for prostate cancer may minimize overtreatment, according to a study published online March 13 in JAMA Oncology. Derya...
